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Dear Editor 
With great interest we read the recent publication from Vinter and colleagues describing the role of 
TNFα in the Aldara model1. Through the use of scoring skin inflammation, RT-PCR, and histology, 
they showed that TNFα-deficient mice showed less erythema, scaling, epidermal hyperplasia, Ki67, 
CD3+ T cells staining and splenomegaly. The authors continued by quantifying several mediating 
cytokines, such as IL-17A, IL-22, IL-12p40, and IL-23p19; which were significantly reduced in TNFα-
knockouts. They also quantified interferon regulatory factor (IRF) -7, which on day 1 was clearly 
elevated in response to Aldara. Similar dynamics and levels were observed in TNFα-knockouts. 
Therefore, the authors conclude that TNFα does not affect the early type I interferon response. 
However, we believe this statement is not sufficiently supported by their study and kindly refer the 
authors to our previous study with TNFR1-knockout mice, which showed a sustained type I 
interferon response within hours after application2. First, we found that IFNα levels in the skin 
decreased in response to repetitive Aldara treatment. In contrast, TNFR1-knockouts showed steady 
levels instead. Measurement of IFNα and IFNβ in wild type serum revealed a peak at 3 hours after 
Aldara, whereas the levels kept increasing in the absence of TNFR1. A similar trend was found in the 
expression levels of Cxcl10, Ifit2, and Usp18; interferon-responsive genes. We attribute these results 
to the TNF/TNFR1 pathway negatively regulating type I interferon production in response to Aldara.  
Since TNFα may act through two different receptors, TNFR1 and TNFR2, it is difficult to interpret 
results obtained with TNFα-knockout mice only. Yet, similar to the findings of Vinter and coworkers, 
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Consequently, we believe that the sole measurement of IRF7 after 24 hours  of application, does not 
capture sufficient evidence to state that TNFα is dispensable for early type I interferons in the Aldara 
model. Nevertheless, the findings of Vinter et al. are still relevant as they reaffirm the use of the 
Aldara model in mice since loss of TNFα leads to amelioration of inflammatory parameters, similarly 
to what is observed in patients treated with TNFα-inhibitors. 
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